How has Ionis Pharmaceuticals's other commercial liabilities changed year-over-year?

Ionis Pharmaceuticals's other commercial liabilities increased by 23.2% year-over-year, from $102.74M to $126.55M.

What is the long-term trend for Ionis Pharmaceuticals's other commercial liabilities?

Over 5 years (2020 to 2025), Ionis Pharmaceuticals's other commercial liabilities has grown at a 3.3% compound annual growth rate (CAGR), from $90.16M to $106.09M.

Ionis Pharmaceuticals IONS Other Commercial Liabilities

Other Commercial Liabilities at other companies

Arrowhead ResearchARWR

——

ALN

Alnylam PharmaceuticalsALNY

——

Roivant SciencesROIV

——

Jazz PharmaceuticalsJAZZ

——

Johnson & JohnsonJNJ

——

AmgenAMGN

——

Other financials

Income statement

See full

Revenue$246.1M+87.0%

Gross profit$243.1M+86.8%

Operating income-$117.4M+20.0%

Net income-$92.5M+37.0%

EPS (diluted)-$0.56+39.8%

Balance sheet

See full

Cash & equivalents$173.4M-34.4%

Total debt$691.7M+334%

Total equity$491.4M+3.3%

Total assets$3.4B+22.6%

Cash flow

See full

Operating cash flow-$792.8M-426%

CapEx$21.8M+73.0%

Free cash flow-$814.6M-399%

Valuation

See full

Market cap$12.25B+159%

Enterprise value$12.77B+175%

P/S11.6×+5.0×

Profitability

See full

Gross margin98.4%-0.2pp

Operating margin-33.3%-11.0pp

Net margin-30.9%-10.5pp

FCF margin-77.4%+35.3pp

Returns & leverage

See full

Return on equity-67.6%-20.3pp

Debt / equity1.4×+1.1×

Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ionis Pharmaceuticals's other commercial liabilities?: Ionis Pharmaceuticals (IONS) reported other commercial liabilities of $126.55M in Q1 2026.
How has Ionis Pharmaceuticals's other commercial liabilities changed year-over-year?: Ionis Pharmaceuticals's other commercial liabilities increased by 23.2% year-over-year, from $102.74M to $126.55M.
What is the long-term trend for Ionis Pharmaceuticals's other commercial liabilities?: Over 5 years (2020 to 2025), Ionis Pharmaceuticals's other commercial liabilities has grown at a 3.3% compound annual growth rate (CAGR), from $90.16M to $106.09M.